This event has passed.

Webinar: Using DILIsym to Predict Hepatoxicity Risk During Pre-clinical Development

Name: Webinar: Using DILIsym to Predict Hepatoxicity Risk During Pre-clinical Development
Start: 2019-07-25T07:00:00-07:00
End: 2019-07-25T08:30:00-07:00

July 25, 2019 @ 7:00 am - 8:30 am

Using DILIsym to Predict Hepatoxicity Risk During Pre-clinical Development

Presented by SOLVO Biotechnology & GlaxoSmithKline

July 25

7:00 AM – 8:30 AM PDT

+ Google Calendar + Add to iCalendar

Details

Date:: July 25, 2019
Time:: 7:00 am - 8:30 am
Website:: https://register.gotowebinar.com/register/228885735598136577

Webinar: Using DILIsym to Predict Hepatoxicity Risk During Pre-clinical Development

July 25, 2019 @ 7:00 am - 8:30 am

Details

In Case You Missed A Recent Webinar or Product Video:

What’s new in MonolixSuite 2021

ADMET Predictor® 10.3 (APX.3): Flagship machine learning platform for ADMET modeling